Literature DB >> 18705984

What should we do with asymptomatic carotid stenosis?

Anne L Abbott1, Christopher F Bladin, Christopher R Levi, Brian R Chambers.   

Abstract

The benefit of prophylactic carotid endarterectomy (CEA) for patients with asymptomatic severe carotid stenosis in the major randomised surgical studies was small, expensive and may now be absorbed by improvements in best practice medical intervention. Strategies to identify patients with high stroke risk are needed. If surgical intervention is to be considered the complication rates of individual surgeons should be available. Clinicians will differ in their interpretation of the same published data. Maintaining professional relationships with clinicians from different disciplines often involves compromise. As such, the management of a patient will, in part, depend on what kind of specialist the patient is referred to. The clinician's discussion with patients about this complex issue must be flexible to accommodate differing patient expectations. Ideally, patients prepared to undergo surgical procedures should be monitored in a trial setting or as part of an audited review process to increase our understanding of current practice outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 18705984     DOI: 10.1111/j.1747-4949.2007.00096.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  14 in total

1.  Intensive medical therapy for asymptomatic carotid artery stenosis.

Authors:  Pratik Bhattacharya; Seemant Chaturvedi
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

2.  Cognitive and physical performance in patients with asymptomatic carotid artery disease.

Authors:  Nancy C Landgraff; Susan L Whitney; Elaine N Rubinstein; Howard Yonas
Journal:  J Neurol       Date:  2010-01-23       Impact factor: 4.849

Review 3.  Carotid Artery Stenosis in Women.

Authors:  Michael J McArdle; Anne L Abbott; Zvonimir Krajcer
Journal:  Tex Heart Inst J       Date:  2018-08-01

Review 4.  Asymptomatic carotid stenosis: intervention or just stick to medical therapy--the case for medical therapy.

Authors:  Jonathan Y Streifler
Journal:  J Neural Transm (Vienna)       Date:  2011-02-08       Impact factor: 3.575

5.  Association between excessive supraventricular ectopy and subclinical cerebrovascular disease: a population-based study.

Authors:  T Hisamatsu; K Miura; A Fujiyoshi; A Kunimura; T Ito; I Miyazawa; S Torii; A Shiino; K Nozaki; H Kanda; H Arima; T Ohkubo; H Ueshima
Journal:  Eur J Neurol       Date:  2019-05-09       Impact factor: 6.089

Review 6.  Extra-Cranial Carotid Artery Stenosis: An Objective Analysis of the Available Evidence.

Authors:  Anne L Abbott
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

7.  Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational study.

Authors:  Hugh S Markus; Alice King; Martin Shipley; Raffi Topakian; Marisa Cullinane; Sheila Reihill; Natan M Bornstein; Arjen Schaafsma
Journal:  Lancet Neurol       Date:  2010-05-31       Impact factor: 44.182

8.  Prediction of asymptomatic carotid artery stenosis in the general population: identification of high-risk groups.

Authors:  Marjolein de Weerd; Jacoba P Greving; Bo Hedblad; Matthias W Lorenz; Ellisiv B Mathiesen; Daniel H O'Leary; Maria Rosvall; Matthias Sitzer; Gert Jan de Borst; Erik Buskens; Michiel L Bots
Journal:  Stroke       Date:  2014-07-03       Impact factor: 7.914

9.  Endovascular treatment for restenosis of carotid venous bypass graft: a clinical case report.

Authors:  Alberto Bramucci; Claudio Bianchini Massoni; Roberto Menozzi; Alessandro Ucci; Enrico Epifani; Antonio Freyrie
Journal:  Acta Biomed       Date:  2021-04-30

10.  Silent cortical neuronal damage in atherosclerotic disease of the major cerebral arteries.

Authors:  Hiroshi Yamauchi; Ryuichi Nishii; Tatsuya Higashi; Shinya Kagawa; Hidenao Fukuyama
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-29       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.